Xeris Pharmaceuticals Revenue 2017-2019 | XERS

Xeris Pharmaceuticals revenue from 2017 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Xeris Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $2
2017 $2
2016 $1
Xeris Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $0
Q2 2019 $0
Q1 2019 $0
Q4 2018 $1
Q3 2018 $1
Q2 2018 $1
Q1 2018 $0
Q4 2017
Q3 2017 $0
Q2 2017 $1
Q4 2016
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.167B $0.002B
Xeris Pharmaceuticals, Inc. produces peptides, proteins, antibodies, molecules, auto-injectors, multi-dose pens and infusion pumps to treat endocrine and metabolic diseases. The company's proprietary formulation technologies consist of XeriSol (TM) and XeriJect(TM). Xeris Pharmaceuticals, Inc. is based in Chicago, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.986B 39.47
Takeda Pharmaceutical (TAK) Japan $62.405B 9.86
Astellas Pharma (ALPMY) Japan $32.601B 16.28
Eisai (ESALY) Japan $21.377B 41.22
Merck (MKGAF) Germany $16.627B 22.69
Grifols, S.A (GRFS) Spain $16.212B 21.24
Neurocrine Biosciences (NBIX) United States $9.887B 466.78
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.901B 36.21
Ionis Pharmaceuticals (IONS) United States $8.730B 17.68
Jazz Pharmaceuticals (JAZZ) Ireland $8.641B 11.04
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
IPSEN SA ADR (IPSEY) France $7.424B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hypermarcas (HYPMY) Brazil $5.703B 20.50
Arrowhead Pharmaceuticals (ARWR) United States $5.449B 82.51
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Nektar Therapeutics (NKTR) United States $4.132B 0.00
United Therapeutics (UTHR) United States $4.056B 0.00
Sage Therapeutics (SAGE) United States $3.882B 0.00
Evotec AG (EVTCY) Germany $3.809B 62.32
FibroGen (FGEN) United States $3.706B 108.92
Taro Pharmaceutical Industries (TARO) Israel $3.305B 12.17
PTC Therapeutics (PTCT) United States $3.174B 0.00
ArQule (ARQL) United States $2.417B 0.00
Zogenix (ZGNX) United States $2.415B 0.00
ChemoCentryx (CCXI) United States $2.186B 0.00
Tilray (TLRY) Canada $2.147B 0.00
Xencor (XNCR) United States $2.126B 64.62
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.104B 0.00
Heron Therapeutics (HRTX) United States $2.020B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.003B 63.85
Pacira Pharmaceuticals (PCRX) United States $1.774B 52.47
USANA Health Sciences (USNA) United States $1.734B 18.50
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.534B 10.47
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.447B 17.58
Theravance Biopharma (TBPH) Cayman Islands $1.438B 0.00
Endo (ENDP) Ireland $1.331B 2.45
Enanta Pharmaceuticals (ENTA) United States $1.163B 26.56
Portola Pharmaceuticals (PTLA) United States $1.160B 0.00
Karyopharm Therapeutics (KPTI) United States $1.155B 0.00
Aerie Pharmaceuticals (AERI) United States $1.136B 0.00
Dermira (DERM) United States $1.044B 0.00
Radius Health (RDUS) United States $0.970B 0.00
Akebia Therapeutics (AKBA) United States $0.890B 0.00
Collegium Pharmaceutical (COLL) United States $0.808B 0.00
ImmunoGen (IMGN) United States $0.741B 0.00
Flexion Therapeutics (FLXN) United States $0.696B 0.00
TherapeuticsMD (TXMD) United States $0.692B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.615B 0.00
Translate Bio (TBIO) United States $0.513B 0.00
Molecular Templates (MTEM) United States $0.509B 0.00
Organogenesis Holdings (ORGO) United States $0.493B 0.00
DURECT (DRRX) United States $0.489B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.456B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.452B 54.88
Corbus Pharmaceuticals Holdings (CRBP) United States $0.449B 0.00
Siga Technologies (SIGA) United States $0.423B 9.67
BioCryst Pharmaceuticals (BCRX) United States $0.423B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.419B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.410B 17.68
Innate Pharma SA (IPHYF) France $0.403B 0.00
OptiNose (OPTN) United States $0.383B 0.00
Lannett Co Inc (LCI) United States $0.379B 4.41
Spectrum Pharmaceuticals (SPPI) United States $0.374B 0.00
Recro Pharma (REPH) United States $0.370B 0.00
Harpoon Therapeutics (HARP) United States $0.364B 0.00
Calithera Biosciences (CALA) United States $0.351B 0.00
Indivior (INVVY) United States $0.347B 1.25
Rafael Holdings (RFL) United States $0.320B 0.00
KalVista Pharmaceuticals (KALV) United States $0.303B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.290B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.265B 0.00
Jounce Therapeutics (JNCE) United States $0.256B 3.42
MEI Pharma (MEIP) United States $0.242B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.228B 0.00
Concordia (CXRXF) Canada $0.225B 0.00
Ocular Therapeutix (OCUL) United States $0.218B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.214B 0.00
IMV INC (IMV) Canada $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 32.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
CannTrust Holdings (CTST) Canada $0.166B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.158B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.140B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.130B 0.00
CV Sciences (CVSI) United States $0.113B 0.00
Aquestive Therapeutics (AQST) United States $0.109B 0.00
Otonomy (OTIC) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Champions Oncology (CSBR) United States $0.100B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.092B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.085B 0.00
PolarityTE (PTE) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
CTI BioPharma (CTIC) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.27
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
AgeX Therapeutics (AGE) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.064B 15.86
Entasis Therapeutics Holdings (ETTX) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Iterum Therapeutics (ITRM) Ireland $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Onconova Therapeutics (ONTX) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
IsoRay (ISR) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Biomerica (BMRA) United States $0.028B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
VAXART, INC (VXRT) United States $0.019B 0.00
Cardiome Pharma (CORV) Canada $0.019B 0.00
Shineco (TYHT) China $0.018B 0.00
NOVAN INC (NOVN) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Vical (BBI) United States $0.012B 0.00
Lipocine (LPCN) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Hemispherx BioPharma (AIM) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00